Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
Oct 13, 2026, 01:44

Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients

Debadrita Ray, Assistant Professor at Department of Hematology PGIMER Chandigarh, shared a post on LinkedIn:

“Delighted to share our recent work:

‘Effect of Blood Group on von Willebrand Factor Antigen Levels in Compensated Advanced Chronic Liver Disease and Utility of von Willebrand Factor–Platelet Ratio for Detecting Clinically Significant Portal Hypertension.’

We evaluated von Willebrand factor (vWF) antigen and the vWF–platelet ratio (VITRO) for detecting clinically significant portal hypertension (CSPH) in a prospective cohort of patients with compensated advanced chronic liver disease (cACLD) at PGIMER, Chandigarh.”

Title: Effect of Blood Group on von Willebrand Factor Antigen Levels in Compensated Advanced Chronic Liver Disease and Utility of von Willebrand Factor–Platelet Ratio for Detecting Clinically Significant Portal Hypertension

Authors: Ritesh Sharma, Debadrita Ray, Arka De, Arpit Shastri, Divjot S. Lamba, Naveen Bhagat, Nipun Verma, Sunil Taneja, Mahinder Kumar, Harish Bhujade, Naveen Kalra, Narender Kumar, Jasmina Ahluwalia, Ajay Duseja

Debadrita Ray

Stay updated on all scientific advances with Hemostasis Today.